EndoPil: A Magnetically Actuated Swallowable Capsule for Weight Management: Development and Trials

Area of Science:

• Biomedical Engineering
• Gastroenterology
• Medical Devices

Background:

• Obesity is a growing global health crisis, associated with severe comorbidities like heart disease, diabetes, and cancer.
• Current intragastric balloon (IGB) therapies for obesity often involve invasive procedures, tethers, or endoscopic assistance, leading to discomfort, cost, and potential complications.

Purpose of the Study:

• To develop and evaluate a novel, tetherless, magnetically actuated capsule (EndoPil) for self-deploying an intragastric balloon (IGB).
• To demonstrate the safety and feasibility of this new IGB delivery system in preclinical and human studies.

Main Methods:

• A magnetically actuated capsule (EndoPil) was designed to swallow and deploy an IGB via a chemical reaction triggered by an external magnet.
• Simulations and bench-top tests assessed magnetic actuation, valve mechanism, and balloon inflation.
• Preclinical animal and human trials were conducted to evaluate safety and feasibility.

Main Results:

• A prototype capsule (13 mm x 35 mm) was successfully developed.
• Magnetic actuation reliably triggered the chemical reaction, inflating a biocompatible balloon (approx. 120 mL).
• Animal and human trials confirmed the safety and feasibility of the magnetic deployment system.

Conclusions:

• The EndoPil system presents a promising, tetherless, and magnetically actuated approach for IGB delivery.
• This novel method offers a potentially more comfortable, cost-effective, and safer alternative for obesity management and comorbidity improvement.